Baxter Income Taxes 2010-2024 | BAX

Baxter annual/quarterly income taxes history and growth rate from 2010 to 2024. Income taxes can be defined as the total amount of income tax expense for the given period.
  • Baxter income taxes for the quarter ending June 30, 2024 were $0.054B, a 440% increase year-over-year.
  • Baxter income taxes for the twelve months ending June 30, 2024 were $73M, a 370.37% decline year-over-year.
  • Baxter annual income taxes for 2023 were $-0.034B, a 950% decline from 2022.
  • Baxter annual income taxes for 2022 were $0.004B, a 95.18% decline from 2021.
  • Baxter annual income taxes for 2021 were $0.083B, a 54.4% decline from 2020.
Baxter Annual Income Taxes
(Millions of US $)
2023 $-34
2022 $4
2021 $83
2020 $182
2019 $-41
2018 $65
2017 $491
2016 $-12
2015 $35
2014 $33
2013 $60
2012 $555
2011 $553
2010 $463
2009 $519
Baxter Quarterly Income Taxes
(Millions of US $)
2024-06-30 $54
2024-03-31 $77
2023-12-31 $165
2023-09-30 $-223
2023-06-30 $10
2023-03-31 $14
2022-12-31 $3
2022-09-30 $-54
2022-06-30 $34
2022-03-31 $21
2021-12-31 $-58
2021-09-30 $-1
2021-06-30 $91
2021-03-31 $51
2020-12-31 $39
2020-09-30 $56
2020-06-30 $42
2020-03-31 $45
2019-12-31 $-204
2019-09-30 $106
2019-06-30 $13
2019-03-31 $44
2018-12-31 $101
2018-09-30 $-146
2018-06-30 $61
2018-03-31 $49
2017-12-31 $352
2017-09-30 $42
2017-06-30 $42
2017-03-31 $55
2016-12-31 $39
2016-09-30 $1
2016-06-30 $6
2016-03-31 $-58
2015-12-31 $15
2015-09-30 $-35
2015-06-30 $34
2015-03-31 $14
2014-12-31 $-18
2014-09-30 $27
2014-06-30 $134
2014-03-31 $146
2013-12-31 $115
2013-09-30 $136
2013-06-30 $153
2013-03-31 $141
2012-12-31 $72
2012-09-30 $183
2012-06-30 $156
2012-03-31 $144
2011-12-31 $76
2011-09-30 $149
2011-06-30 $174
2011-03-31 $154
2010-12-31 $41
2010-09-30 $117
2010-06-30 $133
2010-03-31 $172
2009-12-31 $139
2009-09-30 $126
2009-06-30 $135
2009-03-31 $119
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $17.458B $14.813B
Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $202.584B 25.84
Stryker (SYK) United States $144.427B 32.55
Boston Scientific (BSX) United States $130.404B 37.49
Medtronic (MDT) Ireland $113.203B 16.84
EssilorLuxottica (ESLOY) France $112.107B 0.00
Lonza Group Ag (LZAGY) Switzerland $45.279B 0.00
Haleon (HLN) United Kingdom $43.049B 27.97
GE HealthCare Technologies (GEHC) United States $39.012B 20.24
ResMed (RMD) United States $36.507B 30.00
Terumo (TRUMY) Japan $30.649B 43.28
Koninklijke Philips (PHG) Netherlands $24.871B 19.04
Zimmer Biomet Holdings (ZBH) United States $21.791B 13.87
Insulet (PODD) United States $19.339B 77.01
Smith & Nephew SNATS (SNN) United Kingdom $10.816B 0.00
Bio-Rad Laboratories (BIO) United States $10.245B 34.82
BellRing Brands (BRBR) United States $9.218B 38.97
Demant (WILYY) Denmark $8.351B 0.00
Lantheus Holdings (LNTH) United States $5.846B 13.58
TG Therapeutics (TGTX) United States $4.785B 0.00
Haemonetics (HAE) United States $4.590B 22.40
ICU Medical (ICUI) United States $4.354B 41.56
Prestige Consumer Healthcare (PBH) United States $4.039B 20.09
Perrigo (PRGO) Ireland $3.645B 10.73
Envista Holdings (NVST) United States $3.571B 26.60
Neogen (NEOG) United States $3.554B 41.00
Agios Pharmaceuticals (AGIO) United States $3.448B 0.00
GN Store Nord (GNNDY) Denmark $3.068B 19.67
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
QuidelOrtho (QDEL) United States $2.891B 18.61
LeMaitre Vascular (LMAT) United States $2.372B 57.65
Warby Parker (WRBY) United States $2.084B 0.00
AtriCure (ATRC) United States $1.862B 0.00
Green Thumb Industries (GTBIF) United States $1.651B 28.90
InMode (INMD) Israel $1.638B 9.85
Maravai LifeSciences Holdings (MRVI) United States $1.458B 0.00
AdaptHealth (AHCO) United States $1.405B 10.05
BioLife Solutions (BLFS) United States $1.227B 0.00
Curaleaf Holdings (CURLF) Canada $1.079B 0.00
Phibro Animal Health (PAHC) United States $1.035B 18.25
Owens & Minor (OMI) United States $1.031B 8.05
CeriBell (CBLL) United States $0.983B 0.00
National Vision Holdings (EYE) United States $0.931B 31.10
Capricor Therapeutics (CAPR) United States $0.887B 0.00
Evolus (EOLS) United States $0.831B 0.00
VAREX IMAGING (VREX) United States $0.598B 18.04
Quanterix (QTRX) United States $0.588B 0.00
Surmodics (SRDX) United States $0.549B 0.00
Verano Holdings (VRNOF) United States $0.546B 0.00
Cresco Labs (CRLBF) United States $0.508B 0.00
Valneva SE (VALN) France $0.417B 0.00
ZimVie (ZIMV) United States $0.394B 33.19
Canopy Growth (CGC) Canada $0.379B 0.00
Cerus (CERS) United States $0.377B 0.00
Viemed Healthcare (VMD) United States $0.370B 35.22
OraSure Technologies (OSUR) United States $0.316B 21.20
Biote (BTMD) United States $0.312B 14.38
Sanara MedTech (SMTI) United States $0.306B 0.00
Zynex (ZYXI) United States $0.296B 62.00
MacroGenics (MGNX) United States $0.276B 0.00
Aurora Cannabis (ACB) Canada $0.262B 0.00
Jin Medical (ZJYL) China $0.250B 0.00
Omeros (OMER) United States $0.249B 0.00
Utah Medical Products (UTMD) United States $0.238B 16.05
High Tide (HITI) Canada $0.213B 88.33
TerrAscend (TSNDF) Canada $0.196B 0.00
Brainsway (BWAY) Israel $0.180B 216.00
Organigram Holdings (OGI) Canada $0.169B 0.00
FitLife Brands (FTLF) United States $0.155B 20.99
Rockwell Medical (RMTI) United States $0.144B 0.00
Zevia PBC (ZVIA) United States $0.140B 0.00
TriSalus Life Sciences (TLSI) United States $0.137B 0.00
Quipt Home Medical (QIPT) United States $0.117B 0.00
Veru (VERU) United States $0.106B 0.00
Fonar (FONR) United States $0.094B 9.76
Oramed Pharmaceuticals (ORMP) United States $0.094B 23.20
Cellectar Biosciences (CLRB) United States $0.086B 0.00
Ayr Wellness (AYRWF) United States $0.081B 0.00
Sanuwave Health (SNWVD) United States $0.079B 2.69
Modular Medical (MODD) United States $0.072B 0.00
InterCure (INCR) Israel $0.066B 0.00
Safety Shot (SHOT) United States $0.061B 0.00
Apyx Medical (APYX) United States $0.056B 0.00
MariMed (MRMD) United States $0.055B 0.00
Jushi Holdings (JUSHF) United States $0.053B 0.00
Exagen (XGN) United States $0.052B 0.00
Cytosorbents (CTSO) United States $0.051B 0.00
Allurion Technologies (ALUR) United States $0.047B 0.00
ImmuCell (ICCC) United States $0.028B 0.00
Nephros (NEPH) United States $0.017B 0.00
Flora Growth (FLGC) United States $0.016B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.011B 0.00
GlucoTrack (GCTK) United States $0.008B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Agape ATP (ATPC) $0.006B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Senestech (SNES) United States $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 13.60
SNDL (SNDL) Canada $0.000B 0.00